Marc S Rendell. Expert Rev Endocrinol Metab 2018
Times Cited: 6
Times Cited: 6
Times Cited
Times Co-cited
Similarity
Thiazolidinediones in the treatment of insulin resistance and type II diabetes.
A R Saltiel, J M Olefsky. Diabetes 1996
A R Saltiel, J M Olefsky. Diabetes 1996
33
Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
Yoshihito Ohtake, Tsutomu Sato, Takamitsu Kobayashi, Masahiro Nishimoto, Naoki Taka, Koji Takano, Keisuke Yamamoto, Masayuki Ohmori, Marina Yamaguchi, Kyoko Takami,[...]. J Med Chem 2012
Yoshihito Ohtake, Tsutomu Sato, Takamitsu Kobayashi, Masahiro Nishimoto, Naoki Taka, Koji Takano, Keisuke Yamamoto, Masayuki Ohmori, Marina Yamaguchi, Kyoko Takami,[...]. J Med Chem 2012
33
Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus.
Sumihiro Nomura, Shigeki Sakamaki, Mitsuya Hongu, Eiji Kawanishi, Yuichi Koga, Toshiaki Sakamoto, Yasuo Yamamoto, Kiichiro Ueta, Hirotaka Kimata, Keiko Nakayama,[...]. J Med Chem 2010
Sumihiro Nomura, Shigeki Sakamaki, Mitsuya Hongu, Eiji Kawanishi, Yuichi Koga, Toshiaki Sakamoto, Yasuo Yamamoto, Kiichiro Ueta, Hirotaka Kimata, Keiko Nakayama,[...]. J Med Chem 2010
33
Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects.
Zhuang Miao, Gianluca Nucci, Neeta Amin, Raman Sharma, Vincent Mascitti, Meera Tugnait, Alfin D Vaz, Ernesto Callegari, Amit S Kalgutkar. Drug Metab Dispos 2013
Zhuang Miao, Gianluca Nucci, Neeta Amin, Raman Sharma, Vincent Mascitti, Meera Tugnait, Alfin D Vaz, Ernesto Callegari, Amit S Kalgutkar. Drug Metab Dispos 2013
33
Na(+)-glucose cotransporter (SGLT) inhibitors as antidiabetic agents. 4. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives substituted on the B ring.
K Tsujihara, M Hongu, K Saito, H Kawanishi, K Kuriyama, M Matsumoto, A Oku, K Ueta, M Tsuda, A Saito. J Med Chem 1999
K Tsujihara, M Hongu, K Saito, H Kawanishi, K Kuriyama, M Matsumoto, A Oku, K Ueta, M Tsuda, A Saito. J Med Chem 1999
33
Discovery of a Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor (HSK0935) for the Treatment of Type 2 Diabetes.
Yao Li, Zongjun Shi, Lei Chen, Suxin Zheng, Sheng Li, Bo Xu, Zhenhong Liu, Jianyu Liu, Chongyang Deng, Fei Ye. J Med Chem 2017
Yao Li, Zongjun Shi, Lei Chen, Suxin Zheng, Sheng Li, Bo Xu, Zhenhong Liu, Jianyu Liu, Chongyang Deng, Fei Ye. J Med Chem 2017
33
Exploration of O-spiroketal C-arylglucosides as novel and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.
Binhua Lv, Baihua Xu, Yan Feng, Kun Peng, Ge Xu, Jiyan Du, Lili Zhang, Wenbin Zhang, Ting Zhang, Liangcheng Zhu,[...]. Bioorg Med Chem Lett 2009
Binhua Lv, Baihua Xu, Yan Feng, Kun Peng, Ge Xu, Jiyan Du, Lili Zhang, Wenbin Zhang, Ting Zhang, Liangcheng Zhu,[...]. Bioorg Med Chem Lett 2009
33
Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors.
Vincent Mascitti, Tristan S Maurer, Ralph P Robinson, Jianwei Bian, Carine M Boustany-Kari, Thomas Brandt, Benjamin M Collman, Amit S Kalgutkar, Michelle K Klenotic, Michael T Leininger,[...]. J Med Chem 2011
Vincent Mascitti, Tristan S Maurer, Ralph P Robinson, Jianwei Bian, Carine M Boustany-Kari, Thomas Brandt, Benjamin M Collman, Amit S Kalgutkar, Michelle K Klenotic, Michael T Leininger,[...]. J Med Chem 2011
33
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control.
Martin R Cowie, Miles Fisher. Nat Rev Cardiol 2020
Martin R Cowie, Miles Fisher. Nat Rev Cardiol 2020
33
New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones.
K L Kees, J J Fitzgerald, K E Steiner, J F Mattes, B Mihan, T Tosi, D Mondoro, M L McCaleb. J Med Chem 1996
K L Kees, J J Fitzgerald, K E Steiner, J F Mattes, B Mihan, T Tosi, D Mondoro, M L McCaleb. J Med Chem 1996
33
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
Wei Meng, Bruce A Ellsworth, Alexandra A Nirschl, Peggy J McCann, Manorama Patel, Ravindar N Girotra, Gang Wu, Philip M Sher, Eamonn P Morrison, Scott A Biller,[...]. J Med Chem 2008
Wei Meng, Bruce A Ellsworth, Alexandra A Nirschl, Peggy J McCann, Manorama Patel, Ravindar N Girotra, Gang Wu, Philip M Sher, Eamonn P Morrison, Scott A Biller,[...]. J Med Chem 2008
33
Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
Nicole C Goodwin, Ross Mabon, Bryce A Harrison, Melanie K Shadoan, Zheng Y Almstead, Yiling Xie, Jason Healy, Lindsey M Buhring, Christopher M DaCosta, Jennifer Bardenhagen,[...]. J Med Chem 2009
Nicole C Goodwin, Ross Mabon, Bryce A Harrison, Melanie K Shadoan, Zheng Y Almstead, Yiling Xie, Jason Healy, Lindsey M Buhring, Christopher M DaCosta, Jennifer Bardenhagen,[...]. J Med Chem 2009
33
Pharmacokinetics and Pharmacodynamics of Tofogliflozin (a Selective SGLT2 Inhibitor) in Healthy Male Subjects.
Nahoko Kasahara-Ito, Hiroyuki Fukase, Yoichiro Ogama, Tomohisa Saito, Yasuhiro Ohba, Sumire Shimada, Yasuki Takano, Tomoko Ichihara, Kimio Terao, Noboru Nakamichi,[...]. Drug Res (Stuttg) 2017
Nahoko Kasahara-Ito, Hiroyuki Fukase, Yoichiro Ogama, Tomohisa Saito, Yasuhiro Ohba, Sumire Shimada, Yasuki Takano, Tomoko Ichihara, Kimio Terao, Noboru Nakamichi,[...]. Drug Res (Stuttg) 2017
33
Discovery of MK-8282 as a Potent G-Protein-Coupled Receptor 119 Agonist for the Treatment of Type 2 Diabetes.
Santhosh F Neelamkavil, Andrew W Stamford, Timothy Kowalski, Dipshikha Biswas, Craig Boyle, Samuel Chackalamannil, Yan Xia, Charles Jayne, Bernard Neustadt, Jinsong Hao,[...]. ACS Med Chem Lett 2018
Santhosh F Neelamkavil, Andrew W Stamford, Timothy Kowalski, Dipshikha Biswas, Craig Boyle, Samuel Chackalamannil, Yan Xia, Charles Jayne, Bernard Neustadt, Jinsong Hao,[...]. ACS Med Chem Lett 2018
20
Adipose Tissue Function and Expandability as Determinants of Lipotoxicity and the Metabolic Syndrome.
Stefania Carobbio, Vanessa Pellegrinelli, Antonio Vidal-Puig. Adv Exp Med Biol 2017
Stefania Carobbio, Vanessa Pellegrinelli, Antonio Vidal-Puig. Adv Exp Med Biol 2017
16
Utility of Continuous Metabolic Syndrome Score in Assessing Risk of Type 2 Diabetes: The Isfahan Diabetes Prevention Study.
Mohsen Janghorbani, Masoud Amini. Ann Nutr Metab 2016
Mohsen Janghorbani, Masoud Amini. Ann Nutr Metab 2016
33
Systems Biology of Metabolism: A Driver for Developing Personalized and Precision Medicine.
Jens Nielsen. Cell Metab 2017
Jens Nielsen. Cell Metab 2017
16
Continuous and Dichotomous Metabolic Syndrome Definitions in Youth Predict Adult Type 2 Diabetes and Carotid Artery Intima Media Thickness: The Cardiovascular Risk in Young Finns Study.
Costan G Magnussen, Sanith Cheriyan, Matthew A Sabin, Markus Juonala, Juha Koskinen, Russell Thomson, Michael R Skilton, Mika Kähönen, Tomi Laitinen, Leena Taittonen,[...]. J Pediatr 2016
Costan G Magnussen, Sanith Cheriyan, Matthew A Sabin, Markus Juonala, Juha Koskinen, Russell Thomson, Michael R Skilton, Mika Kähönen, Tomi Laitinen, Leena Taittonen,[...]. J Pediatr 2016
16
Patterns of clustering of the metabolic syndrome components and its association with coronary heart disease in the Multi-Ethnic Study of Atherosclerosis (MESA): A latent class analysis.
Seyed Mohammad Riahi, Soraya Moamer, Mahshid Namdari, Yaser Mokhayeri, Mohammad Amin Pourhoseingholi, Seyed Saeed Hashemi-Nazari. Int J Cardiol 2018
Seyed Mohammad Riahi, Soraya Moamer, Mahshid Namdari, Yaser Mokhayeri, Mohammad Amin Pourhoseingholi, Seyed Saeed Hashemi-Nazari. Int J Cardiol 2018
16
The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes.
Juan Pablo Frias, Edward J Bastyr, Louis Vignati, Matthias H Tschöp, Christophe Schmitt, Klara Owen, Rune Haubo Christensen, Richard D DiMarchi. Cell Metab 2017
Juan Pablo Frias, Edward J Bastyr, Louis Vignati, Matthias H Tschöp, Christophe Schmitt, Klara Owen, Rune Haubo Christensen, Richard D DiMarchi. Cell Metab 2017
16
Abdominal obesity phenotypes and incident diabetes over 12 years of follow-up: The Tehran Lipid and glucose study.
Farahnaz Salehinia, Hengameh Abdi, Farzad Hadaegh, Sara Serahati, Majid Valizadeh, Fereidoun Azizi, Farhad Hosseinpanah. Diabetes Res Clin Pract 2018
Farahnaz Salehinia, Hengameh Abdi, Farzad Hadaegh, Sara Serahati, Majid Valizadeh, Fereidoun Azizi, Farhad Hosseinpanah. Diabetes Res Clin Pract 2018
16
American College of Endocrinology position statement on the insulin resistance syndrome.
Daniel Einhorn, Gerald M Reaven, Rhoda H Cobin, Earl Ford, Om P Ganda, Yehuda Handelsman, Richard Hellman, Paul S Jellinger, David Kendall, Ronald M Krauss,[...]. Endocr Pract 2003
Daniel Einhorn, Gerald M Reaven, Rhoda H Cobin, Earl Ford, Om P Ganda, Yehuda Handelsman, Richard Hellman, Paul S Jellinger, David Kendall, Ronald M Krauss,[...]. Endocr Pract 2003
16
Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome.
Siegfried Ussar, Shiho Fujisaka, C Ronald Kahn. Mol Metab 2016
Siegfried Ussar, Shiho Fujisaka, C Ronald Kahn. Mol Metab 2016
16
16
Design, synthesis, and biological evaluation of novel pan agonists of FFA1, PPARγ and PPARδ.
Zheng Li, Zongtao Zhou, Fengjian Deng, Yuyi Li, Danjun Zhang, Luyong Zhang. Eur J Med Chem 2018
Zheng Li, Zongtao Zhou, Fengjian Deng, Yuyi Li, Danjun Zhang, Luyong Zhang. Eur J Med Chem 2018
16
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis.
M Angelyn Bethel, Rishi A Patel, Peter Merrill, Yuliya Lokhnygina, John B Buse, Robert J Mentz, Neha J Pagidipati, Juliana C Chan, Stephanie M Gustavson, Nayyar Iqbal,[...]. Lancet Diabetes Endocrinol 2018
M Angelyn Bethel, Rishi A Patel, Peter Merrill, Yuliya Lokhnygina, John B Buse, Robert J Mentz, Neha J Pagidipati, Juliana C Chan, Stephanie M Gustavson, Nayyar Iqbal,[...]. Lancet Diabetes Endocrinol 2018
16
Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)
B Balkau, M A Charles. Diabet Med 1999
B Balkau, M A Charles. Diabet Med 1999
16
Use of a Metabolic Syndrome Severity Z Score to Track Risk During Treatment of Prediabetes: An Analysis of the Diabetes Prevention Program.
Mark D DeBoer, Stephanie L Filipp, Matthew J Gurka. Diabetes Care 2018
Mark D DeBoer, Stephanie L Filipp, Matthew J Gurka. Diabetes Care 2018
16
Cardiovascular efficacy and safety of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a systematic review and network meta-analysis.
H Hussein, F Zaccardi, K Khunti, S Seidu, M J Davies, L J Gray. Diabet Med 2019
H Hussein, F Zaccardi, K Khunti, S Seidu, M J Davies, L J Gray. Diabet Med 2019
16
Browning of white adipose tissue: lessons from experimental models.
Thereza Cristina Lonzetti Bargut, Vanessa Souza-Mello, Marcia Barbosa Aguila, Carlos Alberto Mandarim-de-Lacerda. Horm Mol Biol Clin Investig 2017
Thereza Cristina Lonzetti Bargut, Vanessa Souza-Mello, Marcia Barbosa Aguila, Carlos Alberto Mandarim-de-Lacerda. Horm Mol Biol Clin Investig 2017
16
Design and validation of a population-based definition of the metabolic syndrome.
Carlos A Aguilar-Salinas, Rosalba Rojas, Clicerio Gonzalez-Villalpando, Francisco J Gómez-Pérez, Roopa Mehta, Gustavo Olaiz, Juan A Rull, David R Cox. Diabetes Care 2006
Carlos A Aguilar-Salinas, Rosalba Rojas, Clicerio Gonzalez-Villalpando, Francisco J Gómez-Pérez, Roopa Mehta, Gustavo Olaiz, Juan A Rull, David R Cox. Diabetes Care 2006
20
The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis.
Clair Crewe, Yu Aaron An, Philipp E Scherer. J Clin Invest 2017
Clair Crewe, Yu Aaron An, Philipp E Scherer. J Clin Invest 2017
16
Pyruvate kinase L/R is a regulator of lipid metabolism and mitochondrial function.
Zhengtao Liu, Cheng Zhang, Sunjae Lee, Woonghee Kim, Martina Klevstig, Azadeh M Harzandi, Natasa Sikanic, Muhammad Arif, Marcus Ståhlman, Jens Nielsen,[...]. Metab Eng 2019
Zhengtao Liu, Cheng Zhang, Sunjae Lee, Woonghee Kim, Martina Klevstig, Azadeh M Harzandi, Natasa Sikanic, Muhammad Arif, Marcus Ståhlman, Jens Nielsen,[...]. Metab Eng 2019
16
Metabolic syndrome: definitions and controversies.
Eva Kassi, Panagiota Pervanidou, Gregory Kaltsas, George Chrousos. BMC Med 2011
Eva Kassi, Panagiota Pervanidou, Gregory Kaltsas, George Chrousos. BMC Med 2011
16
Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.
K G M M Alberti, P Zimmet, J Shaw. Diabet Med 2006
K G M M Alberti, P Zimmet, J Shaw. Diabet Med 2006
16
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.
K G Alberti, P Z Zimmet. Diabet Med 1998
K G Alberti, P Z Zimmet. Diabet Med 1998
16
Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery.
Sten Madsbad, Carsten Dirksen, Jens J Holst. Lancet Diabetes Endocrinol 2014
Sten Madsbad, Carsten Dirksen, Jens J Holst. Lancet Diabetes Endocrinol 2014
16
Childhood obesity: a systems medicine approach.
William L Stone, Karen Schetzina, Charles Stuart. Front Biosci (Landmark Ed) 2016
William L Stone, Karen Schetzina, Charles Stuart. Front Biosci (Landmark Ed) 2016
50
Guideline Recommendations for Obesity Management.
Donna H Ryan, Scott Kahan. Med Clin North Am 2018
Donna H Ryan, Scott Kahan. Med Clin North Am 2018
16
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.
Varman T Samuel, Gerald I Shulman. J Clin Invest 2016
Varman T Samuel, Gerald I Shulman. J Clin Invest 2016
16
A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More?
Gaurav Chikara, Pramod Kumar Sharma, Pradeep Dwivedi, Jaykaran Charan, Sneha Ambwani, Surjit Singh. Indian J Clin Biochem 2018
Gaurav Chikara, Pramod Kumar Sharma, Pradeep Dwivedi, Jaykaran Charan, Sneha Ambwani, Surjit Singh. Indian J Clin Biochem 2018
16
Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis.
Ying-Bin Hu, Xin-Yu Liu, Wei Zhan. Drug Des Devel Ther 2018
Ying-Bin Hu, Xin-Yu Liu, Wei Zhan. Drug Des Devel Ther 2018
16
Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
Florencia Halperin, Su-Ann Ding, Donald C Simonson, Jennifer Panosian, Ann Goebel-Fabbri, Marlene Wewalka, Osama Hamdy, Martin Abrahamson, Kerri Clancy, Kathleen Foster,[...]. JAMA Surg 2014
Florencia Halperin, Su-Ann Ding, Donald C Simonson, Jennifer Panosian, Ann Goebel-Fabbri, Marlene Wewalka, Osama Hamdy, Martin Abrahamson, Kerri Clancy, Kathleen Foster,[...]. JAMA Surg 2014
16
Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis.
Alison J Dunkley, Danielle H Bodicoat, Colin J Greaves, Claire Russell, Thomas Yates, Melanie J Davies, Kamlesh Khunti. Diabetes Care 2014
Alison J Dunkley, Danielle H Bodicoat, Colin J Greaves, Claire Russell, Thomas Yates, Melanie J Davies, Kamlesh Khunti. Diabetes Care 2014
16
Regulation of hepatic glucose metabolism in health and disease.
Max C Petersen, Daniel F Vatner, Gerald I Shulman. Nat Rev Endocrinol 2017
Max C Petersen, Daniel F Vatner, Gerald I Shulman. Nat Rev Endocrinol 2017
16
Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome.
Juan de Toro-Martín, Benoit J Arsenault, Jean-Pierre Després, Marie-Claude Vohl. Nutrients 2017
Juan de Toro-Martín, Benoit J Arsenault, Jean-Pierre Després, Marie-Claude Vohl. Nutrients 2017
16
Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort.
Tze Pin Ng, Liang Feng, Ma Shwe Zin Nyunt, Lei Feng, Qi Gao, May Li Lim, Simon L Collinson, Mei Sian Chong, Wee Shiong Lim, Tih Shih Lee,[...]. JAMA Neurol 2016
Tze Pin Ng, Liang Feng, Ma Shwe Zin Nyunt, Lei Feng, Qi Gao, May Li Lim, Simon L Collinson, Mei Sian Chong, Wee Shiong Lim, Tih Shih Lee,[...]. JAMA Neurol 2016
16
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.
Renger G Tiessen, Ciara A Kennedy, Bradley T Keller, Nancy Levin, Lisette Acevedo, Bronislava Gedulin, Andre A van Vliet, Alejandro Dorenbaum, Melissa Palmer. BMC Gastroenterol 2018
Renger G Tiessen, Ciara A Kennedy, Bradley T Keller, Nancy Levin, Lisette Acevedo, Bronislava Gedulin, Andre A van Vliet, Alejandro Dorenbaum, Melissa Palmer. BMC Gastroenterol 2018
16
Assessing Baseline and Temporal Changes in Cardiometabolic Risk Using Metabolic Syndrome Severity and Common Risk Scores.
Matthew J Gurka, Stephanie L Filipp, Thomas A Pearson, Mark D DeBoer. J Am Heart Assoc 2018
Matthew J Gurka, Stephanie L Filipp, Thomas A Pearson, Mark D DeBoer. J Am Heart Assoc 2018
16
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.